Nisha Nanda
Director/Board Member en MORPHIC HOLDING, INC. .
Fortuna: - $ al 31/03/2024
Perfil
Nisha Nanda is an Independent Director at Morphic Holding, Inc. She previously worked as a Senior Director-Clinical Science at Onyx Pharmaceuticals, Inc. from 2012 to 2014.
She then served as the Chief Development Officer at Loxo Oncology, Inc. from 2019 to 2023.
Dr. Nanda holds undergraduate and doctorate degrees from The University of New South Wales.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
MORPHIC HOLDING, INC.
-.--% | 01/04/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Cargos activos de Nisha Nanda
| Empresas | Cargo | Inicio |
|---|---|---|
| MORPHIC HOLDING, INC. | Director/Board Member | 19/08/2021 |
Antiguos cargos conocidos de Nisha Nanda.
| Empresas | Cargo | Fin |
|---|---|---|
| LOXO ONCOLOGY INC | Corporate Officer/Principal | 01/05/2023 |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Corporate Officer/Principal | 01/02/2014 |
Formación de Nisha Nanda.
| The University of New South Wales | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| MORPHIC HOLDING, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |
Loxo Oncology, Inc.
 Loxo Oncology, Inc. Pharmaceuticals: MajorHealth Technology Loxo Oncology, Inc. is a biopharmaceutical company, which engages in the development of small molecule therapeutics for the treatment of cancer. It focuses on genetic alterations, targeted therapies, and genetic testing. The company was founded by Joshua H. Bilenker in May 2013 and is headquartered in Stamford, CT. | Health Technology |
- Bolsa de valores
- Insiders
- Nisha Nanda
